Similar articles

• Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects.

  Arii S. Arii S. Int J Clin Oncol. 2010 Jun;15(3):234. doi: 10.1007/s10147-010-0090-5. Epub 2010 May 27. Int J Clin Oncol. 2010. PMID: 20505970 No abstract available.
• Strategies for HCC target discovery.

  Molina-Sánchez P, Lujambio A. Molina-Sánchez P, et al. Aging (Albany NY). 2017 Apr;9(4):1088-1089. doi: 10.18632/aging.101233. Aging (Albany NY). 2017. PMID: 28455974 Free PMC article. No abstract available.
• Genomic profiling of cell lines for personalized targeted therapy for hepatocellular carcinoma.

  Deshmukh M, Hoshida Y. Deshmukh M, et al. Hepatology. 2013 Dec;58(6):2207. doi: 10.1002/hep.26407. Epub 2013 Oct 10. Hepatology. 2013. PMID: 23519950 Free PMC article. No abstract available.
• Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.

  Yau T, Pang R, Chan P, Poon RT. Yau T, et al. Expert Opin Pharmacother. 2010 Sep;11(13):2187-98. doi: 10.1517/14656561003724705. Expert Opin Pharmacother. 2010. PMID: 20707757 Review.
• [Hepatocellular carcinoma: molecular pathogenesis and novel targets for therapy].

  Marquardt JU, Galle PR, Teufel A. Marquardt JU, et al. Dtsch Med Wochenschr. 2012 Apr;137(16):855-60. doi: 10.1055/s-0032-1304843. Epub 2012 Apr 11. Dtsch Med Wochenschr. 2012. PMID: 22495921 Review. German.